CGA
DXR icon

Crescent Grove Advisors’s Daxor DXR Stock Holding History

Crescent Grove Advisors’s Portfolio DXR Stock Details DXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
12,423
+1,700
+16% +$17.2K 0.01% 296
2026
Q1 		$104K Buy
+10,723
New +$131K 0.01% 300

Other funds holding DXR

TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Aristides Capital Louisville, Kentucky $514M AUM 29.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Crescent Grove Advisors's DXR Position: Q2 2026 in Review

Crescent Grove Advisors increased its Daxor (DXR) stake by 16% in Q2 2026, buying an estimated $17.2K and bringing the position to 12,423 shares worth $128K. The position accounts for 0.01% of the portfolio, ranked #296.

Crescent Grove Advisors first reported a position in DXR in Q1 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold DXR as of Q2 2026.

  • Crescent Grove Advisors held 12,423 shares of Daxor worth $128K as of Q2 2026.
  • Crescent Grove Advisors bought 1,700 Daxor shares in Q2 2026, an estimated $17.2K.
  • Daxor made up 0.01% of Crescent Grove Advisors's portfolio in Q2 2026, its #296 holding.
  • Crescent Grove Advisors first reported a position in Daxor in Q1 2026 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Daxor as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.